The regression discontinuity design showed to be a valid alternative to a randomized controlled trial for estimating treatment effects

Iris L. Maas, Sandra Nolte, Otto B. Walter, Thomas Berger, Martin Hautzinger, Fritz Hohagen, Wolfgang Lutz, Björn Meyer, Johanna Schröder, Christina Späth, Jan Philipp Klein, Steffen Moritz, Matthias Rose*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The regression discontinuity design showed to be a valid alternative to a randomized controlled trial for estimating treatment effects'. Together they form a unique fingerprint.

Medicine & Life Sciences